NCT04427618View on ClinicalTrials.gov

Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

October 3, 2021

Study Completion Date

February 1, 2022

Conditions
Postpartum HemorrhageTranexamic Acid
Interventions
DRUG

Tranexamic acid

Intravenous 1g TXA (500mg/5ml, given intermittent over approximately 10 minutes) given within approximately 10 minutes before skin incision

DRUG

Normal saline

Intravenous 10ml normal saline (placebo) given within approximately 10 minutes before skin incision

Trial Locations (1)

Unknown

KK Women's and Children's Hospital, Singapore

All Listed Sponsors
lead

KK Women's and Children's Hospital

OTHER_GOV

NCT04427618 - Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section | Biotech Hunter | Biotech Hunter